Archimedes
ProStrakan pays £230m for Archimedes
July 14, 2014Sales and Marketing Archimedes, Cancer, ProStrakan, pain, pecfent
The ProStrakan Group is to looking to expand its offerings via a payment of £230 million for Archimedes Pharma. The …
Funds keep Archimedes Pharma buoyant
March 3, 2010Research and Development Archimedes, funding
Archimedes Pharma has completed the biggest fundraising by a private European biotech in 15 years by securing £65 million. The …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
